Method of treating apraxia of speech in children
US9089563B2 · kind B2 · utility
1Cited by
4References
9Claims
0Family size
Assignee
Inventor
Key dates
| Filing date | May 17, 2012 |
| Grant date | Jul 28, 2015 |
| Priority date | — |
| Expiry date | May 17, 2032 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61P25/00
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
A therapeutic method for treating apraxia of speech in children. The child can also be diagnosed with autism, mental retardation, dyslexia. Verbal development stages and nonverbal development stages are tested and observed. If a child demonstrates at least 18 to 24 month development stage of either the verbal development or the non-verbal development, a therapeutic dosage of dopamine agonistic medicine is administered to the child in addition to speech therapy and language training.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.